Dry Eye Test (fluorescein sodium) NDC 51801-008

NDC codes

FDA NDC Directory

Product NDC (as listed)51801-008Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51801-0008Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51801-008-15	51801000815	50 POUCH in 1 CARTON (51801-008-15) / 2 STRIP in 1 POUCHMarketed from Dec 5, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dry Eye Test
Generic name (nonproprietary): fluorescein sodium
Active ingredients: Fluorescein sodium — .12 mg/1
Dosage form: Strip
Route: Ophthalmic
Labeler: Nomax Inc.
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Dec 5, 2013
Listing expires: Dec 31, 2026
Other FDA classes: Dyes (Mechanism)
Identifiers: Product ID 51801-008_7490418c-b489-4b90-bc3d-33ed71231e2dSPL ID 7490418c-b489-4b90-bc3d-33ed71231e2dSPL set ID 04866053-f973-471e-b3bc-241fb76303a2UNII 93X55PE38X
Pharmacologic class: Diagnostic Dye

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451801000815 followed by a unit qualifier and the quantity

Package 51801-0008-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 23, 2019.

Indications (excerpt from the label)

INDICATIONS For testing tear film stability by determining the fluorescein break-up time (FBUT).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)